Coronary Bifurcation Stenting: Review of Current Techniques and
Evidence

Surya   Kiran   Aedma; Anant      Naik; Arun      Kanmanthareddy
doi:10.2174/1573403X18666220406113517
Abstract

Background: Coronary bifurcation stenting constitutes 20% of all PCI performed. Given the extensive prevalence of bifurcation lesions, various techniques have sought to optimally stent the bifurcation to improve revascularization while also decreasing rates of stent thrombosis and lesion recurrence. Advanced techniques, such as planned two-stent approaches, have been shown to have improved outcomes but also require fluoroscopy and procedure time, posing an economic argument as well as a patient-outcome one.
Objective: Because of the many strategies posited in the literature, it becomes essential to objectively evaluate evidence from randomized controlled trials and meta-analyses to help determine the optimal stenting strategy.
Methods: We reviewed the clinical evidence on the efficacy of coronary bifurcation stenting.
Results: In this paper, we review the most recent randomized controlled trials and meta-analyses on the efficacy of various stenting techniques and advances in stenting technologies published to gauge the current state of understanding and chart where the field is heading.
Conclusion: Bifurcation stenting is a maturing problem in the field of interventional cardiology that is adapting to the needs of the patients and advances in technology.
Keywords: Coronary bifurcation lesions, percutaneous coronary intervention, review, Culotte, DK Crush, bifurcation stenting.
[1]
Colombo A, Stankovic G. Bifurcations and branch vessel stenting. Textb Interv Cardiol  2012; 270-87.

[2]
Medina A, Suárez de Lezo J, Pan M. Una clasificación simple de las lesiones coronarias en bifurcación. Rev Esp Cardiol  2006; 59(2): 183.
 [http://dx.doi.org/10.1157/13084649] [PMID: 16540043]

[3]
Bennett J, Dubois C. Coronary bifurcation lesions: Is less more? J Thorac Dis  2016; 8(10): E1351-4.
 [http://dx.doi.org/10.21037/jtd.2016.10.32] [PMID: 27867625]

[4]
Collins N, Seidelin PH, Daly P, et al. Long-term outcomes after percutaneous coronary intervention of bifurcation narrowings. Am J Cardiol  2008; 102(4): 404-10.
 [http://dx.doi.org/10.1016/j.amjcard.2008.03.075] [PMID: 18678296]

[5]
Brilakis E. Bifurcations. In: Brilakis E, Ed. Manual of Percutaneous Coronary Interventions.  Elsevier 2021; pp. 267-301.
 [http://dx.doi.org/10.1016/B978-0-12-819367-9.00016-0]

[6]
Steigen TK, Maeng M, Wiseth R, et al. Randomized study on simple versus complex stenting of coronary artery bifurcation lesions: The Nordic bifurcation study. Circulation  2006; 114(18): 1955-61.
 [http://dx.doi.org/10.1161/CIRCULATIONAHA.106.664920] [PMID: 17060387]

[7]
Lefeand̀vre T, Louvard Y, Morice MC, Loubeyre C, Pieand́chaud JF, Dumas P. Stenting of bifurcation lesions: A rational approach. J Interv Cardiol.   2001; 14: pp. 573-85.

[8]
Burzotta F, Gwon HC, Hahn JY, et al. Modified T-stenting with intentional protrusion of the side-branch stent within the main vessel stent to ensure ostial coverage and facilitate final kissing balloon: The T-stenting and small protrusion technique (TAPstenting). Report of bench testing and first clinical Italian-Korean two-centre experience. Catheter Cardiovasc Interv  2007; 70(1): 75-82.
 [http://dx.doi.org/10.1002/ccd.21194] [PMID: 17585382]

[9]
Chevalier B, Glatt B, Royer T, Guyon P. Placement of coronary stents in bifurcation lesions by the “culotte” technique. Am J Cardiol  1998; 82(8): 943-9.
 [http://dx.doi.org/10.1016/S0002-9149(98)00510-4] [PMID: 9794349]

[10]
Porto I, van Gaal W, Banning A. “Crush” and “reverse crush” technique to treat a complex left main stenosis. Heart  2006; 92(8): 1021.
 [http://dx.doi.org/10.1136/hrt.2005.073221] [PMID: 16844850]

[11]
Colombo A, Stankovic G, Orlic D, et al. Modified T-stenting technique with crushing for bifurcation lesions: Immediate results and 30-day outcome. Catheter Cardiovasc Interv  2003; 60(2): 145-51.
 [http://dx.doi.org/10.1002/ccd.10622] [PMID: 14517916]

[12]
Rakhimov K, Buono A, Anadol R, et al. Randomised, noninferiority, controlled procedural outcomes TrIal comParing reverseT And Protrusion versus double-kissing and crush stenting: Protocol of the TIP TAP I randomised trial. BMJ Open  2020; 10(6): e034264.
 [http://dx.doi.org/10.1136/bmjopen-2019-034264] [PMID: 32554736]

[13]
Kervinen K, Niemelä M, Romppanen H, et al. Clinical outcome after crush versus culotte stenting of coronary artery bifurcation lesions: The nordic stent technique study 36-month follow-up results. JACC Cardiovasc Interv  2013; 6(11): 1160-5.
 [http://dx.doi.org/10.1016/j.jcin.2013.06.009] [PMID: 24262616]

[14]
Ferenc M, Gick M, Comberg T, et al. Culotte stenting vs. TAP stenting for treatment of de-novo coronary bifurcation lesions with the need for side-branch stenting: The Bifurcations Bad Krozingen (BBK) II angiographic trial. Eur Heart J  2016; 37(45): 3399-405.
 [http://dx.doi.org/10.1093/eurheartj/ehw345] [PMID: 27578807]

[15]
Ferenc M, Gick M, Kienzle RP, et al. Randomized trial on routine vs. provisional T-stenting in the treatment of de novo coronary bifurcation lesions. Eur Heart J  2008; 29(23): 2859-67.
 [http://dx.doi.org/10.1093/eurheartj/ehn455] [PMID: 18845665]

[16]
Colombo A, Bramucci E, Saccà S, et al. Randomized study of the crush technique versus provisional side-branch stenting in true coronary bifurcations: The CACTUS (coronary bifurcations: Application of the crushing technique using Sirolimus-Eluting stents) study. Circulation  2009; 119(1): 71-8.
 [http://dx.doi.org/10.1161/CIRCULATIONAHA.108.808402] [PMID: 19103990]

[17]
Mortier P, Hikichi Y, Foin N, et al. Provisional stenting of coronary bifurcations: Insights into final kissing balloon post-dilation and stent design by computational modeling. JACC Cardiovasc Interv  2014; 7(3): 325-33.
 [http://dx.doi.org/10.1016/j.jcin.2013.09.012] [PMID: 24650404]

[18]
Ford TJ, McCartney P, Corcoran D, et al. Single- versus 2-stent strategies for coronary bifurcation lesions: A systematic review and meta-analysis of randomized trials with long-term follow-up. J Am Heart Assoc  2018; 7(11): e008730.
 [http://dx.doi.org/10.1161/JAHA.118.008730] [PMID: 29802145]

[19]
Zhong M, Tang B, Zhao Q, Cheng J, Jin Q, Fu S. Should kissing balloon inflation after main vessel stenting be routine in the onestent approach? A systematic review and meta-analysis of randomized trials. PLoS One  2018; 13(6): e0197580.
 [http://dx.doi.org/10.1371/journal.pone.0197580] [PMID: 29949587]

[20]
Lv YH, Guo C, Li M, Zhang M-B, Wang Z-L. Modified doublestent strategy may be an optimal choice for coronary bifurcation lesions: A systematic review and meta-analysis. Medicine (Baltimore)  2018; 97(48): e13377.
 [http://dx.doi.org/10.1097/MD.0000000000013377] [PMID: 30508932]

[21]
Chen E, Cai W, Chen LL. Crush versus Culotte stenting techniques for coronary bifurcation lesions: A systematic review and metaanalysis of clinical trials with long-term follow-up. Med (United States)  2019; 98(14): e14865.
 [PMID: 30946314]

[22]
Huang F, Luo ZC. Cardiovascular outcomes associated with crush versus provisional stenting techniques for bifurcation lesions: A systematic review and meta-analysis. BMC Cardiovasc Disord  2019; 19(1): 93.
 [http://dx.doi.org/10.1186/s12872-019-1070-y] [PMID: 31014237]

[23]
Di Gioia G, Sonck J, Ferenc M, et al. Clinical outcomes following coronary bifurcation PCI Techniques: A systematic review and network meta-analysis comprising 5,711 patients. JACC Cardiovasc Interv  2020; 13(12): 1432-44.
 [http://dx.doi.org/10.1016/j.jcin.2020.03.054] [PMID: 32553331]

[24]
Zhou Y, Chen S, Huang L, et al. Definite stent thrombosis after drug-eluting stent implantation in coronary bifurcation lesions: A meta-analysis of 3,107 patients from 14 randomized trials. Catheter Cardiovasc Interv  2018; 92(4): 680-91.
 [http://dx.doi.org/10.1002/ccd.27443] [PMID: 29214736]

[25]
Gao XF, Zhang YJ, Tian NL, et al. Stenting strategy for coronary artery bifurcation with drug-eluting stents: A meta-analysis of nine randomised trials and systematic review. EuroIntervention  2014; 10(5): 561-9.
 [http://dx.doi.org/10.4244/EIJY14M06_06] [PMID: 24970736]

[26]
Mohamed MO, Mamas MA, Nagaraja V, et al. Dedicated Bifurcation stents for coronary bifurcation lesions: A systematic review and meta-analysis of randomized-controlled trials. J Invasive Cardiol  2019; 31(12): E344-55.
 [PMID: 31786525]

[27]
Tondas AE, Mulawarman R, Trifitriana M, Pranata R, Abisha SE, Toruan MPL. A Systematic review of jailed balloon technique for coronary bifurcation lesion: Conventional-jailed balloon technique vs modified-jailed balloon technique. Cardiovasc evascularization Med  2020; 21(10): 1193-9.
 [http://dx.doi.org/10.1016/j.carrev.2020.03.001] [PMID: 32169406]

[28]
Kumsars I, Holm NR, Niemelä M, et al. Randomised comparison of provisional side branch stenting versus a two-stent strategy for treatment of true coronary bifurcation lesions involving a large side branch: The Nordic-Baltic Bifurcation Study IV. Open Heart  2020; 7(1): e000947.
 [PMID: 32076558]

[29]
Zheng XW, Zhao DH, Peng HY, et al. Randomized comparison of the crush versus the culotte stenting for coronary artery bifurcation lesions. Chin Med J (Engl)  2016; 129(5): 505-10.
 [http://dx.doi.org/10.4103/0366-6999.176997] [PMID: 26904982]

[30]
Chen SL, Santoso T, Zhang JJ, et al. Clinical outcome of double kissing crush versus provisional stenting of coronary artery bifurcation lesions: The 5-year follow-up results from a randomized and multicenter DKCRUSH-II study (randomized study on double kissing crush technique versus provisional stenting technique for coronary artery bifurcation lesions). Circ Cardiovasc Interv  2017; 10(2): e004497.
 [http://dx.doi.org/10.1161/CIRCINTERVENTIONS.116.004497] [PMID: 28122805]

[31]
Chen X, Li X, Zhang JJ, et al. 3-year outcomes of the DKCRUSHV Trial Comparing DK crush with provisional stenting for left main bifurcation lesions. JACC Cardiovasc Interv  2019; 12(19): 1927-37.
 [http://dx.doi.org/10.1016/j.jcin.2019.04.056] [PMID: 31521645]

[32]
Jin Z, Song L, Zheng Z, Zhang S, Wang M.  Balloon-stent kissing technique versus jailed wire technique for interventional treatment of coronary bifurcation lesions Comparison of short- and long-term clinical outcomes. Med (United States)  2019; 98-20.

[33]
Hildick-Smith D, Behan MW, Lassen JF, et al. The EBC TWO study (European bifurcation coronary TWO): A Randomized comparison of provisional T-stenting versus a systematic 2 stent culotte strategy in large caliber true bifurcations. Circ Cardiovasc Interv  2016; 9(9): e003643.
 [http://dx.doi.org/10.1161/CIRCINTERVENTIONS.115.003643] [PMID: 27578839]

[34]
Nairooz R, Saad M, Elgendy IY, et al. Long-term outcomes of provisional stenting compared with a two-stent strategy for bifurcation lesions: A meta-analysis of randomised trials. Heart  2017; 103(18): 1427-34.
 [http://dx.doi.org/10.1136/heartjnl-2016-310929] [PMID: 28314731]

[35]
Zimarino M, Corazzini A, Ricci F, Di Nicola M, De Caterina R. Late thrombosis after double versus single drug-eluting stent in the treatment of coronary bifurcations: A meta-analysis of randomized and observational Studies. JACC Cardiovasc Interv  2013; 6(7): 687-95.
 [http://dx.doi.org/10.1016/j.jcin.2013.03.012] [PMID: 23769650]

[36]
Gobeil F, Lefèvre T, Guyon P, et al. Stenting of bifurcation lesions using the bestent: A prospective dual-center study. Catheter Cardiovasc Interv  2002; 55(4): 427-33.
 [http://dx.doi.org/10.1002/ccd.10091] [PMID: 11948886]

[37]
Erglis A, Kumsars I, Niemelä M, et al. Randomized comparison of coronary bifurcation stenting with the crush versus the culotte technique using sirolimus eluting stents: The Nordic stent technique study. Circ Cardiovasc Interv  2009; 2(1): 27-34.
 [http://dx.doi.org/10.1161/CIRCINTERVENTIONS.108.804658] [PMID: 2003169]

[38]
Chen S, Zhang J, Ye F, et al. Final kissing balloon inflation by classic crush stenting did not improve the clinical outcomes for the treatment of unprotected left main bifurcation lesions: The importance of double-kissing crush technique. Catheter Cardiovasc Interv  2008; 71(2): 166-72.
 [http://dx.doi.org/10.1002/ccd.21317] [PMID: 18231996]

[39]
Ge L, Airoldi F, Iakovou I, et al. Clinical and angiographic outcome after implantation of drug-eluting stents in bifurcation lesions with the crush stent technique: Importance of final kissing balloon post-dilation. J Am Coll Cardiol  2005; 46(4): 613-20.
 [http://dx.doi.org/10.1016/j.jacc.2005.05.032] [PMID: 16098424]

[40]
Zhang JJ, Chen SL. Classic crush and DK crush stenting techniques. EuroIntervention  2015; 11 (Suppl. V): V102-5.
 [http://dx.doi.org/10.4244/EIJV11SVA23] [PMID: 25983140]

[41]
Chen S, Zhang J, Ye F, et al. DK crush (double-kissing and double- crush) technique for treatment of true coronary bifurcation lesions: Illustration and comparison with classic crush. J Invasive Cardiol  2007; 19(4): 189-93.
 [PMID: 17404406]

[42]
Ormiston JA, Webster MWI, Webber B, Stewart JT, Ruygrok PN, Hatrick RI. The “crush” technique for coronary artery bifurcation stenting: Insights from micro-computed tomographic imaging of bench deployments. JACC Cardiovasc Interv  2008; 1(4): 351-7.
 [http://dx.doi.org/10.1016/j.jcin.2008.06.003] [PMID: 19463329]

[43]
Hall AB, Chavez I, Garcia S, et al. Double kissing crush bifurcation stenting: Step-by-step troubleshooting. EuroIntervention  2021; 17(4): e317-25.
 [http://dx.doi.org/10.4244/EIJ-D-19-00721] [PMID: 32310131]

[44]
Brilakis ES, Burke MN, Banerjee S. DK-crush should become preferred strategy for treating unprotected LM bifurcation lesions: No pain, no gain. J Am Coll Cardiol  2017; 70(21): 2618-20.
 [http://dx.doi.org/10.1016/j.jacc.2017.09.1083] [PMID: 29096916]

[45]
Lynn BS, Hermiller JB. Treatment of bifurcation lesions: Has DK crush“ed” the competition? Curr Cardiol Rep  2018; 20(10): 101.
 [http://dx.doi.org/10.1007/s11886-018-1024-5] [PMID: 30173390]

[46]
Colombo A, Moses JW, Morice MC, et al. Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions. Circulation  2004; 109(10): 1244-9.
 [http://dx.doi.org/10.1161/01.CIR.0000118474.71662.E3] [PMID: 4981005]

[47]
Chaudhry EC, Dauerman KP, Sarnoski CL, Thomas CS, Dauerman HL. Percutaneous coronary intervention for major bifurcation lesions using the simple approach: Risk of myocardial infarction. J Thromb Thrombolysis  2007; 24(1): 7-13.
 [http://dx.doi.org/10.1007/s11239-006-0004-6] [PMID: 17238005]

[48]
Saito S, Shishido K, Moriyama N, et al. Modified jailed balloon technique for bifurcation lesions. Catheter Cardiovasc Interv  2018; 92(3): E218-26.
 [http://dx.doi.org/10.1002/ccd.27334] [PMID: 29205789]

[49]
Jin Z, Li L, Wang M, Zhang S, Chen Z, Shen Z. Innovative provisionalstenting approach to treat coronary bifurcation lesions: Balloon- stent kissing technique. J Invasive Cardiol  2013; 25(11): 600-4.
 [PMID: 24184895]

[50]
Qu WB, Zhang W, Liu JY, et al. Modified balloon-stent kissing technique avoid side-branch compromise for simple true bifurcation lesions. BMC Cardiovasc Disord  2019; 19(1): 89.
 [http://dx.doi.org/10.1186/s12872-019-1052-0] [PMID: 30961533]

[51]
Testa L, Latini RA, Pizzocri S, et al. Multi-Link Vision stent vs. first-generation drug-eluting stents: Systematic review and metaanalysis. QJM  2011; 104(12): 1025-34.
 [http://dx.doi.org/10.1093/qjmed/hcr138] [PMID: 21896624]

[52]
Schömig A, Neumann FJ, Kastrati A, et al. A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents. N Engl J Med  1996; 334(17): 1084-9.
 [http://dx.doi.org/10.1056/NEJM199604253341702] [PMID: 8598866]

[53]
Stettler C, Wandel S, Allemann S, et al. Outcomes associated with drug-eluting and bare-metal stents: A collaborative network metaanalysis. Lancet  2007; 370(9591): 937-48.
 [http://dx.doi.org/10.1016/S0140-6736(07)61444-5] [PMID: 17869634]

[54]
Pocock SJ. Safety of drug-eluting stents: Demystifying network meta-analysis. Lancet  2007; 370(9605): 2099-100.
 [http://dx.doi.org/10.1016/S0140-6736(07)61898-4] [PMID: 18156025]

[55]
Maluenda G, Lemesle G, Waksman R. A critical appraisal of the safety and efficacy of drug-eluting stents. Clin Pharmacol Ther  2009; 85(5): 474-80.
 [http://dx.doi.org/10.1038/clpt.2009.8] [PMID: 19279567]

[56]
Slottow TLP, Waksman R. Drug-eluting stent safety. Am J Cardiol  2007; 100(8B): 10M-7M.
 [http://dx.doi.org/10.1016/j.amjcard.2007.08.017] [PMID: 17950827]

[57]
Lemesle G, Maluenda G, Collins SD, Waksman R. Drug-eluting stents: Issues of late stent thrombosis. Cardiol Clin  2010; 28(1): 97-105.
 [http://dx.doi.org/10.1016/j.ccl.2009.09.003] [PMID: 19962052]

[58]
Yamawaki M, Muramatsu T, Ashida K, et al. Randomized comparison between 2-link cell design biolimus A9-eluting stent and 3- link cell design everolimus-eluting stent in patients with de novo true coronary bifurcation lesions: The BEGIN trial. Heart Vessels  2019; 34(8): 1297-308.
 [http://dx.doi.org/10.1007/s00380-019-01368-3] [PMID: 30859377]

[59]
Walsh SJ, Hanratty CG, Watkins S, et al. Culotte stenting for coronary bifurcation lesions with 2nd and 3rd generation everolimuseluting stents: The CELTIC Bifurcation Study. EuroIntervention  2018; 14(3): e318-24.
 [http://dx.doi.org/10.4244/EIJ-D-18-00346] [PMID: 29792404]

[60]
Bennett J, Adriaenssens T, McCutcheon K, et al. 5-Year clinical follow-up of the COBRA (complex coronary bifurcation lesions: Randomized comparison of a strategy using a dedicated selfexpanding biolimus A9-eluting stent vs. a culotte strategy using everolimus-eluting stents) study. Catheter Cardiovasc Interv  2018; 92(6): E375-80.
 [http://dx.doi.org/10.1002/ccd.27597] [PMID: 29536609]

[61]
Bennett J, Adriaenssens T, Desmet W, Dubois C. Complex bifurcation lesions: Randomized comparison of a fully bioresorbable modified t stenting strategy versus bifurcation reconstruction with a dedicated self-expanding stent in combination with bioresorbable scaffolds, an OCT study: Rationale and design of the COBRA II trial. Catheter Cardiovasc Interv  2016; 88(6): 843-53.
 [http://dx.doi.org/10.1002/ccd.26571] [PMID: 27184586]

[62]
Gil RJ, Bil J, Grundeken MJ, et al. Regular drug-eluting stents versus the dedicated coronary bifurcation sirolimus-eluting BiOSS LIM® stent: The randomised, multicentre, open-label, controlled POLBOS II trial. EuroIntervention  2016; 12(11): e1404-12.
 [http://dx.doi.org/10.4244/EIJY15M11_11] [PMID: 26600564]

[63]
Yamawaki M, Fujita M, Sasaki S, et al. Randomized comparison between provisional and routine kissing-balloon technique after main vessel crossover stenting for coronary bifurcation lesions. Heart Vessels  2017; 32(9): 1067-76.
 [http://dx.doi.org/10.1007/s00380-017-0977-4] [PMID: 28401352]

[64]
Joner M, Finn AV, Farb A, et al. Pathology of drug-eluting stents in humans: Delayed healing and late thrombotic risk. J Am Coll Cardiol  2006; 48(1): 193-202.
 [http://dx.doi.org/10.1016/j.jacc.2006.03.042] [PMID: 16814667]

[65]
Sharma A, Hai O, Garg A, Vallakati A, Lavie CJ, Marmur JD. Duration of dual antiplatelet therapy following drug-eluting stent implantation: A systematic review and meta-analysis of randomized controlled trials. Curr Probl Cardiol  2017; 42(12): 404-17.
 [http://dx.doi.org/10.1016/j.cpcardiol.2017.04.001] [PMID: 29110813]

[66]
Yang H, Qian J, Huang Z, Ge J. Szabo 2-stent technique for coronary bifurcation lesions: Procedural and short-term outcomes. BMC Cardiovasc Disord  2020; 20(1): 325.
 [http://dx.doi.org/10.1186/s12872-020-01605-y] [PMID: 32635890]

[67]
Oliveira MDP, Ribeiro EE, Campos CM, et al. Four-year clinical follow-up of the first-in-man randomized comparison of a novel sirolimus eluting stent with abluminal biodegradable polymer and ultra-thin strut cobalt-chromium alloy: The INSPIRON-I trial. Cardiovasc Diagn Ther  2015; 5(4): 264-70.
 [PMID: 26331110]

[68]
Gao XF, Ge Z, Kong XQ, et al. 3-year outcomes of the ULTIMATE trial comparing intravascular ultrasound versus angiography-guided drug-eluting stent implantation. JACC Cardiovasc Interv  2021; 14(3): 247-57.
 [http://dx.doi.org/10.1016/j.jcin.2020.10.001] [PMID: 33541535]

[69]
Diletti R, Tchetche D, Barbato E, et al. Bioresorbable scaffolds for treatment of coronary bifurcation lesions: Critical appraisal and future perspectives. Catheter Cardiovasc Interv  2016; 88(3): 397-406.
 [http://dx.doi.org/10.1002/ccd.26454] [PMID: 27143281]

[70]
van Geuns RJ. Bioresorbable scaffolds and bifurcations. Cardiovasc Revascularization Med  2019; 20(1): 4.
 [http://dx.doi.org/10.1016/j.carrev.2018.12.014] [PMID: 30744826]

[71]
Wiebe J, Baquet M, Dörr O, et al. Long-term follow-up and predictors of target lesion failure after implantation of everolimus-eluting bioresorbable scaffolds in real-world practice. Int J Cardiol  2020; 312: 42-7.
 [http://dx.doi.org/10.1016/j.ijcard.2020.02.062] [PMID: 32151443]

[72]
Wiebe J, Hoppmann P, Cassese S, et al. Outcomes after complete dissolution of everolimus-eluting bioresorbable scaffolds implanted during routine practice.Rev Española Cardiol.  2020.

[73]
Toth GG, Ono M, Buschmann E, et al. Usability of Fantom Encore ® scaffold in noncomplex bifurcations–Analysis in bench models. Catheter Cardiovasc Interv 

[74]
Verheye S, Wlodarczak A, Montorsi P, et al. BIOSOLVE-IVregistry: Safety and performance of the Magmaris scaffold: 12-month outcomes of the first cohort of 1,075 patients. Catheter Cardiovasc Interv  2021; 98(1): E1-8.
 [http://dx.doi.org/10.1002/ccd.29260] [PMID: 32881396]

[75]
Rampat R, Mayo T, Hildick-Smith D, Cockburn J. A randomized trial comparing two stent sizing strategies in coronary bifurcation treatment with bioresorbable vascular scaffolds - The Absorb Bifurcation Coronary (ABC) trial. Cardiovasc Revascularization Med  2019; 20(1): 43-9.
 [http://dx.doi.org/10.1016/j.carrev.2018.08.007] [PMID: 30170828]
Rights & Permissions Print Cite
Article Metrics
10
Journal Information
For Authors
For Editors
For Reviewers
Explore Articles
Open Access
Open Access Articles
For Visitors
DOI https://dx.doi.org/10.2174/1573403X18666220406113517	Print ISSN 1573-403X
Publisher Name Bentham Science Publisher	Online ISSN 1875-6557
Current Cardiology Reviews

Coronary Bifurcation Stenting: Review of Current Techniques and Evidence

Abstract Play Pause

Related Journals

Related Books

Abstract
